IL2 and myeloid sarcoma: In order to mimic the elevation of IL-2 expression that is typical of MS we have used the neurotropic potential of HSV-1 and the unique characteristics of the LAT (latency-associated transcript) promoter that is active in most cell types to extend expression of murine IL-2 [13].